Figure 2: Urinary metabolomic profile distinguish GBM patients from healthy controls. (a) Welch’s two-sample t-test was used to identify metabolites that differed significantly between GBM groups (magenta), compared to control (untreated healthy, blue). In this unsupervised clustering, metabolite values are plotted on the y-axis and individual samples are on the x-axis, “group”. Dark blue coloring within the cluster represent elevated metabolite levels and yellow represents decreased metabolite levels. Additionally, along the right most aspect of the cluster the super-pathway for each metabolite is colorcoded.
(b) The confusion matrix from a Random Forest analysis shows that GBM samples could be separated from control samples, with a 77% predictive accuracy. Thirty of 38 control samples and 29 of 39 pre-radiation samples were correctly classified.